Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

PCI better than CABG on achieving targets

Dr Rubin Minhas

CHD Clinical Lead, Medway PCT

Gillingham, Kent

Dr Millar (Letters, 12 November) has raised the comparison of percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) surgery.

Recent reports including Cochrane and the ARTS study show no significant difference in either death or MI to two-three years among PCI or CABG.

Repeat revascularisation has tended to be higher with older bare-metal stents in the PCI arm of these trials, although newer drug-eluting stents (DES) showed no significant difference in overall major adverse cardiac and cerebrovascular events at a year in the ARTS and ARTS II studies.

PCI is less expensive than CABG (2004 NHS reference costs, CABG £7,066, PCI £2,609) and is cost-effective. NICE guidance recommends DES and allows multiple stenting.

PCI has made substantial contributions to NSF revascularisation targets while patients have benefited from a less invasive procedure and shorter waiting times.

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say